This explains why users often report nausea, reduced appetite, spontaneous erections, and changes in libido after injection
These statements describe ingredient-level structure/function mechanisms and have not been evaluated by the Food and Drug Administration
We suggest starting doses using PCCA Naltrexone Hydrochloride USP Anhydrous (PCCA # 50-4377 ), prepared in 0.5 mg capsules with LoxOral (PCCA # 30-4774 ) as the filler, and titrate 0.5 mg every two weeks up to a maximum of 4.5 mg daily
Thats because if you use Phase I supportive supplements as a standalone, they will begin to convert the toxins into intermediate byproducts, but many of these byproducts are more harmful than the original toxins and may not clear from the body if you dont have enough Phase II-supporting amino acids
GSH provides reducing equivalents to antioxidant enzymes, hydroxyl radicals, ROS and is itself oxidized to GSSG